HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,040.00
-60.00 (-1.94%)
Aug 29, 2025, 12:39 PM KST

HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 260.33 billion as of August 28, 2025. Its market cap has decreased by -62.22% in one year.

Market Cap
260.33B
Enterprise Value
291.08B
Revenue
61.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,040.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 260.33B, an increase of 146.05%. That is a compound annual growth rate of 6.01%.

History

DateMarket Cap% Change
Aug 27, 2025260.33B-72.14%
Dec 30, 2024934.49B182.02%
Dec 28, 2023331.36B-9.25%
Dec 29, 2022365.14B-3.64%
Dec 30, 2021378.91B-51.22%
Dec 30, 2020776.71B0.46%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics72.53T
Celltrion37.63T
ALTEOGEN22.61T
Yuhan8,730.14B
SK Biopharmaceuticals7,878.31B
PharmaResearch7,314.31B
Peptron7,303.72B
LigaChem Biosciences5,379.81B
Market Cap Rankings